Regulatory Affairs
NAFDAC Uncovers Suspected Fake Parago Candies, Antibiotic Packaging Materials in Lagos Raids
NAFDAC has uncovered suspected counterfeit Parago candies concealed in a rice warehouse at Iddo Market and packaging materials bearing the names of established antibiotics at Lagos Trade Fair Complex, raising fresh concerns about illegal product manufacturing and public health risks.
The National Agency for Food and Drug Administration and Control (NAFDAC) has uncovered suspected counterfeit confectionery products, unregistered cosmetics and packaging materials linked to established pharmaceutical brands during separate enforcement operations in Lagos State.
The discoveries were made at a warehouse in the Iddo market area and the Tools and Hardware section of the Trade Fair Complex, where the agency's Investigation and Enforcement officers identified concealed products and materials suspected to be associated with illegal manufacturing and packaging activities.
Suspected Counterfeit Parago Candies Found in Rice Warehouse
In an operation at the Iddo market area, NAFDAC officials discovered cartons of Parago candy concealed inside a warehouse reportedly used for storing rice.
According to footage of the operation, the products were hidden beneath a tarpaulin and inside cartons labelled with different product descriptions, including cartons marked "Toy with Candy".
An enforcement officer seen in the video questioned why the Parago products were being stored in cartons bearing different names, suggesting an attempt to conceal their identity and evade detection.
The agency has not publicly disclosed the quantity of candies recovered, the identities of those responsible for the warehouse or whether arrests were made.
NAFDAC Discovers Antibiotic Packaging Materials at Trade Fair Complex
In a separate enforcement operation at the Tools and Hardware Complex within the Lagos Trade Fair Complex, NAFDAC officers uncovered warehouses containing unlabelled and unregistered cosmetics, pharmaceutical packaging materials and other product-related items.
Among the materials displayed during the operation were packaging items bearing the names of established antibiotics, including Augmentin 625mg and AmpliClose capsules.
The agency reportedly identified discrepancies between the recovered Augmentin packaging materials and those used by the original manufacturer, GlaxoSmithKline (GSK).
Officials also discovered leaflets and other packaging materials associated with the medicines, alongside materials bearing the name of Gordon's drinks.
The discovery raises concerns about the possible use of unauthorised packaging materials in the production or repackaging of falsified pharmaceutical products.
However, the recovery of packaging materials alone does not establish that finished counterfeit antibiotics were manufactured at the location or that the recovered materials had already entered circulation.
Unregistered Cosmetics Also Uncovered
The Trade Fair Complex operation also exposed materials and products suspected to be associated with the production and packaging of unregistered cosmetics.
Items displayed by the enforcement team included unidentified soaps, empty shampoo tubes, moisturising lotion containers and packaging materials bearing descriptions such as "Turmeric Vitamin C".
The presence of finished cosmetic products alongside packaging materials raises questions about the regulatory status, manufacturing conditions and quality assurance processes associated with the operation.
NAFDAC has repeatedly warned against the production and circulation of unregistered cosmetics, which may expose consumers to products of unknown composition and safety.
Public Health Implications of Falsified Antibiotics
The discovery of packaging materials bearing the names of established antibiotics is particularly concerning because falsified medicines can compromise treatment and patient safety.
Antibiotics that contain incorrect quantities of active pharmaceutical ingredients, inappropriate substances or no active ingredients may fail to treat bacterial infections effectively.
Such treatment failure can allow infections to persist or worsen, potentially resulting in complications and increased healthcare costs.
The inappropriate use of antibiotics, including exposure to substandard or falsified products, can also contribute to the wider antimicrobial resistance challenge.
NAFDAC had previously issued Public Alert No. 024/2026, dated 30 April 2026, concerning counterfeit Augmentin 625mg tablets bearing batch number AC3N in Nigeria. The agency said the manufacturer, GSK, had confirmed that the suspected product was counterfeit following an investigation that identified discrepancies in its manufacturing and expiry dates, as well as packaging defects.
The earlier alert reinforces the need for continued surveillance of pharmaceutical supply chains and vigilance among pharmacists, distributors, healthcare facilities and consumers.
NAFDAC Urges Public Vigilance
NAFDAC has urged members of the public to remain vigilant, obtain medicines only from authorised and licensed sources and report suspected falsified medicines, unregistered products and illegal manufacturing activities to the agency.
Pharmacists and other healthcare professionals also have an important role in identifying suspicious products, checking the integrity of pharmaceutical packaging and sourcing medicines through legitimate supply chains.
The latest discoveries highlight the importance of sustained regulatory surveillance, intelligence-led enforcement and collaboration among regulators, pharmaceutical professionals and the public to prevent unsafe and falsified products from reaching consumers.
As investigations continue, further information on the quantities recovered, individuals or businesses involved, possible arrests and regulatory actions will be important in establishing the full extent of the activities uncovered.
More like this
NAFDAC Debunks Claims That Camosunate Has Been Banned in Nigeria
21 Nov 2026
NAFDAC Destroys ₦100 Billion Worth of Falsified, Expired and Banned Products in Ogun State
21 Nov 2026
PCN Seals 261 Medicine Outlets Following FCT Enforcement Exercise
20 Nov 2026